In a significant presentation at the European Society of Gene and Cell Therapy (ESGCT) held in Seville, Intellia Therapeutics provided an update on its...
The controversial field of gene-editing technology is experiencing renewed interest following the 2018 announcement by Chinese scientist He Jiankui, who claimed to have engineered...